CRL - James C Foster At Charles River Executes Options Exercise Realizing $1.25M | Benzinga
Disclosed in a recent SEC filing on January 31, Foster, Chairman at Charles River (NYSE:CRL), made a noteworthy transaction involving the exercise of company stock options.
What Happened: In an insider options sale disclosed in a Form 4 filing on Wednesday with the U.S. Securities and Exchange Commission, Foster, Chairman at Charles River, exercised stock options for 17,436 shares of CRL. The transaction value amounted to $1,248,591.
Charles River shares are trading down 0.0% at $216.28 at the time of this writing on Thursday morning. Since the current price is $216.28, this makes Foster's 17,436 shares worth $1,248,591.
All You Need to Know About Charles River
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Key Indicators: Charles River's Financial Health
Revenue Growth: Charles River's remarkable performance in 3 months is ...